[email protected]
CDI - Contrive Datum Insights
Press ReleaseAgriculture

Rodenticides Market to Reach USD 9.08 billion by 2034 at 4.53% CAGR

The global rodenticides market was valued at USD 6.1 billion in 2025. The market is projected to grow from USD 6.37 billion in 2026 to USD 9.08 billion by 2034, exhibiting a compound annual growth rate of 4.53% during the forecast period. Contrive Datum Insights presents this information in its report titled "Rodenticides Market Size, Share & Industry Analysis, By Active ingredient type (First-Generation Anticoagulants, Second-Generation Anticoagulants, Non-Anticoagulants, Fertility Control and Biological, Fumigants and Other Chemicals), Form (Pellets, Blocks, Grain and Whole Bait, Powder and Tracking Dust, Paste and Gel Baits, Liquid Concentrates, Sachets and Soft Baits), Application (Agriculture and Crop Protection, Livestock and Poultry Farms, Residential and Household, Commercial Buildings, Warehouses and Food Processing, Urban and Public Health Control, Conservation and Island Eradication), Target species (Norway Rat (Rattus norvegicus), Roof Rat (Rattus rattus), House Mouse (Mus musculus), Field Rodents and Voles, Other Rodent Species), End user (Professional Pest Control Operators, Farmers and Growers, Households and Consumers, Municipal and Government Agencies, Food and Industrial Facility Operators), Distribution channel (Direct to Pest Control Companies, Agricultural and Pest Control Distributors, Retail Stores, Online Retail, Government Tenders), Dispensing method (Tamper-Resistant Bait Stations, Loose Bait Placement, Bait Boxes and Covered Trays, Tracking Dust Application, Burrow Application and Fumigation, Aerial and Broadcast Baiting), Pack size (Consumer Packs, Professional Packs, Bulk Packs), Regulatory use class (Professional-Only Use, General and Consumer Use, Restricted Use Products, Indoor-Only Use, Outdoor and Agricultural Use), and Regional Forecast, 2026-2034".

PUNE, INDIA — 18 NOVEMBER 2026 — CONTRIVE DATUM INSIGHTS

From USD 6.1 billion in 2025 to USD 9.08 billion in 2034, a 4.53% compound annual rate.

Fastest growth: Fertility Control and Biological at 12.53% a year.

Second-Generation Anticoagulants leads active ingredient type with 52% of 2025 revenue.

Rodenticides are chemical and biological products used to kill or control rats, mice and other rodents that damage crops, stored food, buildings and infrastructure, and that carry disease. The category covers anticoagulant and non-anticoagulant baits, fumigants and emerging fertility control products, sold as pellets, blocks, pastes, powders and liquids. Buyers include professional pest control operators, farmers, food and industrial facility operators, municipal agencies and households.

Urban rodent pressure and outsourced pest control

Urban rodent pressure and outsourced pest control is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 4.53% a year, the active ingredient type lines exposed to it move fastest: Fertility Control and Biological compounds at 12.53%, taking its share of revenue from 3% to 6% and its value from USD 0.183 billion to USD 0.545 billion.

Where the forecast could be beaten: anticoagulant registrations stay in place under professional-use conditions, urban infestation pressure keeps rising and non-anticoagulant products gain approvals faster than expected. The study puts that case at USD 10.22 billion in 2034, against USD 9.08 billion in the base.

The downside is specific. Major markets impose sharp outdoor and consumer anticoagulant bans, resistance spreads faster than new actives are approved and trapping and exclusion methods take volume from bait, and 2034 revenue lands at USD 7.95 billion. Second-Generation Anticoagulants is the drag, 52% of the 2025 base compounding at 3.83% while the market runs at 4.53%.

Where the Competition Actually Sits

Competition in the global rodenticides market runs along the active ingredient type axis, not the regional one. Second-Generation Anticoagulants holds 52% of 2025 revenue at USD 3.172 billion and remains the largest line through 2034 at 48.99%, making it the position hardest for a challenger to take. Fertility Control and Biological, growing at 12.53%, is where share actually changes hands. A supplier established in one is not thereby established in the other, so a field of this size persists in a market of USD 6.1 billion.

Further Report Findings

* * * Second-Generation Anticoagulants was the leading active ingredient type line in 2025, taking 52% of revenue at USD 3.172 billion. * Fertility Control and Biological is projected to grow at 12.53% over the forecast period, the fastest of any active ingredient type line. * By form, Pellets led in 2025 with 28% of revenue at USD 1.708 billion, while Paste and Gel Baits grows fastest at 9.33%. * By application, Agriculture and Crop Protection led in 2025 with 24% of revenue at USD 1.464 billion, while Urban and Public Health Control grows fastest at 6.32%. * By target species, Norway Rat (Rattus norvegicus) led in 2025 with 34% of revenue at USD 2.074 billion, while Field Rodents and Voles grows fastest at 5.45%. * By end user, Professional Pest Control Operators led in 2025 with 38% of revenue at USD 2.318 billion, while Municipal and Government Agencies grows fastest at 5.64%. * By distribution channel, Agricultural and Pest Control Distributors led in 2025 with 36% of revenue at USD 2.196 billion, while Online Retail grows fastest at 11.23%. * By dispensing method, Tamper-Resistant Bait Stations led in 2025 with 38% of revenue at USD 2.318 billion. * By pack size, Professional Packs led in 2025 with 46% of revenue at USD 2.806 billion. * By regulatory use class, Professional-Only Use led in 2025 with 34% of revenue at USD 2.074 billion. * The United States is the largest single country market at USD 1.22 billion in 2025, 20% of global revenue.

Every year from 2020 to 2034 is reported, with revenue and growth for each line across nine axes: by active ingredient type, and by form, application, target species, end user, distribution channel, dispensing method, pack size and regulatory use class. The headline total carries bear, base and bull cases at USD 7.95 billion and USD 10.22 billion by 2034. The study also breaks out all five regions to country level, sets out the competitive landscape, and documents the method behind every estimate. Available as a PDF, with a free sample on request.

Regions Covered
North AmericaEuropeAsia PacificLatin AmericaMiddle East and Africa
About Contrive Datum Insights

Contrive Datum Insights is a global market intelligence and consulting firm working across investment, information technology, healthcare and manufacturing markets. Every market we publish is sized twice — once top-down from the leading players and once bottom-up from the addressable base — and validated by primary interview. More about CDI.

Media contact
[email protected]
Asia Pacific
Kunjir Shyama Prestine, Sr. no. 174/1
Jagtap Diary Road, Pimple Saudagar
Pune 411017, India
+91 983 481 6757
United States
21C2 Lakeshore Dr.
Farmington, CT 06032
United States
+1 215 297 4078